cn

cn is the China-region web presence (cn.ausperbio.com) of AusperBio Therapeutics (Hangzhou Ausper Bio / 杭州浩博医药有限公司), a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment toward a functional cure and advancing oligonucleotide therapeutics. AusperBio leverages its proprietary Med-Oligo ASO platform with targeted delivery technologies to apply antisense oligonucleotide (ASO) therapeutics across viral infections, metabolic conditions, genetic disorders, and immune diseases; its lead candidate AHB-137 is an unconjugated ASO advancing through Phase II/III trials for chronic hepatitis B. Surfaced as a portfolio company of Qiming Venture Partners and added to the API Evangelist network as a stub; the company publishes a marketing website but no public developer or API surface.

cn is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Biopharmaceutical, and Clinical Stage.

🌐 Visit website 📡 Source on GitHub

3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

CompanyBiotechnologyPharmaceuticalsBiopharmaceuticalClinical StageOligonucleotide TherapeuticsHepatitis BDrug Development

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 3.3/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/cn: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: cn
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/cn.png
name: cn
description: cn is the China-region web presence (cn.ausperbio.com) of AusperBio Therapeutics (Hangzhou Ausper Bio / 杭州浩博医药有限公司),
  a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment toward a functional cure and
  advancing oligonucleotide therapeutics. AusperBio leverages its proprietary Med-Oligo ASO platform with targeted delivery
  technologies to apply antisense oligonucleotide (ASO) therapeutics across viral infections, metabolic conditions, genetic
  disorders, and immune diseases; its lead candidate AHB-137 is an unconjugated ASO advancing through Phase II/III trials
  for chronic hepatitis B. Surfaced as a portfolio company of Qiming Venture Partners and added to the API Evangelist network
  as a stub; the company publishes a marketing website but no public developer or API surface.
url: https://raw.githubusercontent.com/api-evangelist/cn/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
x-enrichment: Slug "cn" is a mis-parse of the cn.ausperbio.com regional subdomain; real entity is AusperBio Therapeutics (www.ausperbio.com).
  No developer/API surface exists (marketing SPA only; cms.ausperbio.com is an internal headless CMS, not a public API). No
  OpenAPI, SDKs, MCP, webhooks, or docs to enrich. Domain-security probed; well-known paths all catch-all 200 (no real discovery
  documents).
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Biopharmaceutical
- Clinical Stage
- Oligonucleotide Therapeutics
- Hepatitis B
- Drug Development
tags_raw:
- Company
- Biotechnology
- Pharmaceuticals
- Biopharmaceutical
- Clinical-Stage
- Oligonucleotide Therapeutics
- Hepatitis B
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/cn-domain-security.yml
- type: Website
  url: https://www.ausperbio.com

cn

Kin Score

Security Posture 1

Cn Domain Security

Resources

Access & Security 1

Company 1

Source (apis.yml)